Researchers have successfully differentiated pluripotent stem cells from a patient with ALS into motor neurons and glia featuring an ALS genotype, offering new avenues for drug discovery and understanding the disease process.
Researchers have developed an in vitro model of ALS using embryonic stem cells, providing insights into the disease's mechanisms. The studies suggest that astrocytes may be toxic to motor neurons in ALS, offering a potential target for new therapies.
Researchers have found that 47% of ALS patients exhibit reverse transcriptase activity, suggesting a potential link to retroviruses. Further study is needed to determine if this reflects activation of an endogenous retrovirus or infection with a novel exogenous retrovirus.